How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Short Term Health Insurance Market
- By Plan Type: Fixed Benefit Plans, Indemnity Plans, Hospital Indemnity Plans, Critical Illness Plans, Accident Insurance Plans
- By Coverage Duration: Less than 3 months, 3 to 6 months, 6 to 12 months
- By Distribution Channel: Direct to Consumer (D2C), Insurance Brokers and Agents, Online Insurance Marketplaces, Employer-Sponsored Programs
- By Target Customer Segment: Individual Consumers, Families, Self-Employed Professionals, Unemployed or Transitioning Workers
- By Policy Features: Comprehensive Coverage, Catastrophic Coverage, Maternity Coverage Add-on, Pre-existing Condition Coverage
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Fixed Benefit Plans leads By Plan Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Short Term Health Insurance Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Plan Type 5
Coverage Duration 3
Distribution Channel 4
Target Customer Segment 4
Policy Features 4
Companies profiled
UnitedHealthcare
Blue Cross Blue Shield Association
Aetna (CVS Health)
Cigna
Humana
National General Insurance (Allianz)
Pivot Health
IHC Group
Tivity Health
UnitedHealthcare Global
Oscar Health
Liaison Healthcare
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →UnitedHealthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Blue Cross Blue Shield Association
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Aetna (CVS Health)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Cigna
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Humana
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →National General Insurance (Allianz)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Pivot Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →IHC Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Tivity Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →UnitedHealthcare Global
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Oscar Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Liaison Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →National General Insurance
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →eHealthInsurance
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Health Insurance Innovations
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,176M by 2033 · 5.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fixed Benefit Plans53.3
- Indemnity Plans14.0
- Hospital Indemnity Plans14.4
- Critical Illness Plans9.4
- Accident Insurance Plans8.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$684.8M → $970.7M · 4.5%
Europe$477.3M → $732.0M · 5.5%
Asia Pacific$435.8M → $636.4M · 4.8%
Latin America$269.8M → $403.2M · 5.2%
Middle East and Africa$207.5M → $342.4M · 6.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.422026
5.432027
5.432028
5.452029
5.462030
5.472031
5.502032
5.512033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- UnitedHealthcare21.6
- Blue Cross Blue Shield Association22.1
- Aetna (CVS Health)6.6
- Cigna7.6
- Humana7.2
- National General Insurance (Allianz)6.7
- Others28.2
Segment contribution to growth (%)
Fig. 18 · p.39 →Plan Type14.7%
Coverage Duration25.4%
Distribution Channel24.4%
Target Customer Segment23.7%
Policy Features11.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.5
- Europe23.7
- Asia Pacific20.6
- Latin America13.1
- Middle East and Africa11.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| UnitedHealthcare | 98 | 88 | 75 | 90 | 80 | 92 | 87 |
| Blue Cross Blue Shield Association | 75 | 91 | 74 | 69 | 81 | 68 | 76 |
| Aetna (CVS Health) | 74 | 62 | 79 | 69 | 83 | 69 | 73 |
| Cigna | 81 | 63 | 79 | 68 | 59 | 72 | 70 |
| Humana | 55 | 67 | 58 | 72 | 56 | 73 | 64 |
| National General Insurance (Allianz) | 51 | 67 | 59 | 50 | 62 | 52 | 57 |
| Pivot Health | 55 | 45 | 61 | 47 | 62 | 50 | 53 |
| IHC Group | 55 | 44 | 37 | 49 | 40 | 48 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- UnitedHealthcare
- Blue Cross Blue Shield Association
- Aetna (CVS Health)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| UnitedHealthcare | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Blue Cross Blue Shield Association | ◐ | ✓ | − | ◐ | ✓ | ◐ |
| Aetna (CVS Health) | ◐ | − | ◐ | ✓ | ✓ | ◐ |
| Cigna | ✓ | ◐ | ◐ | ◐ | − | ✓ |
| Humana | − | − | ◐ | ◐ | ◐ | ◐ |
| National General Insurance (Allianz) | − | ◐ | − | − | − | ◐ |
| Pivot Health | − | − | ◐ | − | ◐ | − |
| IHC Group | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1UnitedHealthcare87
2Blue Cross Blue Shield Association76
3Aetna (CVS Health)73
4Cigna70
5Humana64
6National General Insurance (Allianz)57
7Pivot Health53
8IHC Group46
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
UnitedHealthcare
Challenger3
Strong scale, closing on the leaders.
Blue Cross Blue Shield AssociationAetna (CVS Health)Cigna
Contender2
Focused players with pockets of strength.
HumanaNational General Insurance (Allianz)
Niche2
Specialists in a single segment or region.
Pivot HealthIHC Group
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Plan Type in North America, then scale across Short Term Health Insurance Market — a $36M beachhead inside a $593M market.
Beachhead (SOM)$36Mobtainable near-term
Serviceable (SAM)$234Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Fixed Benefit Plans
Best fit — highest urgency & budget in Plan Type.
Economic buyer76 fit
Indemnity Plans
Strong fit — clear ROI and a fast path to value.
End user69 fit
Hospital Indemnity Plans
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Plan Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Coverage Duration & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Distribution Channel
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve22%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Plan Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Short Term Health Insurance Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified25%
Evaluation11%
Closed-won7%
$18.4KCAC
$65KLTV
3.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Short Term Health Insurance Market is a durable-growth opportunity — $7.39B by 2033, compounding at 6.6%.
TAM · 2025$4.43Btoday
TAM · 2033$7.39Bforecast
CAGR6.6%2027–2033
Cumulative$52.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.39BTotal addressable market
SAM$2.69BServiceable available market
SOM$520MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.6% CAGR
Demand compounds through 2033, outpacing GDP across Plan Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Plan Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.39BLarge & growingTAM by 2033 at 6.6% CAGR
$2.69BServiceable nowreachable with today’s model
$520MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.76BBear4.3% CAGR
$7.39BBase6.6% CAGR
$9.46BBull8.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Coverage Duration optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Short Term Health Insurance Market — a $1.80B market by 2033. Plan: grow share from 8.1% to 14.0%.
Market size · 2033$1.80Btotal addressable
Market CAGR6.6%2027–2033
Target share14.0%from 8.1% today
Revenue ambition$251Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.1% | 14.0% | Behind |
| Revenue | $152M | $251M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 31.8% | 40.7% | On track |
| Customer retention | 88.1% | 92.5% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Plan Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Coverage Duration capability
A defensible second engine — invest in Coverage Duration to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Plan Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Coverage Duration
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $32M capacity & capability investment
- Greenlight bolt-on M&A in Coverage Duration
- Authorise North America expansion plan
- Fund R&D program for Plan Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Short Term Health Insurance Market conversation — a $7.34B market you can size, segment and defend in minutes.
Market size · 2033$7.34Btotal opportunity
Growth3.5%CAGR to 2033
Addressable buyers1,023+accounts in scope
Typical ROI5.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Plan Type
Goal Grow share in Plan Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.1×return on cost, year one
< 3 mopayback period
$86K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
UnitedHealthcareBlue Cross Blue Shield AssociationAetna (CVS Health)CignaHumanaNational General Insurance (Allianz)Pivot HealthIHC Group+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Short Term Health Insurance Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Short Term Health Insurance Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Acute Myeloid Leukemia Biomarker Detection Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportAcute Myeloid Leukemia (AML) Biomarker Testing Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportAcute Migraine Medications Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportAcute Lymphoid Leukemia Treatment Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportAcute Lymphocytic Leukemia Diagnostics Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportAcute Lymphocytic Leukemia (ALL) Treatment Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportAcute Lymphoblastic Testing Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportAcute Lung Injury Treatment Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportAcute Liver Failure Treatment Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportAcute Kidney Injury Therapeutics Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportAcute Kidney Injury Drugs Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportAcute Kidney Injury (AKI) Equipment Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.